Patients with metastatic non-small cell lung cancer and PD-L1 expression in Germany. Treatment and first outcome data from the prospective German Registry CRISP (AIO-TRK-0315). 14. Oktober 2019 Sebastian M, Eberhardt WEE, Losem C, Bernhardt C, Maintz C, Marschner N, Jaenicke M, Fleitz A, Spring L, Sahlmann J, Karatas A, Hipper A, Weichert W, Hoffknecht P, Grah C, Rittmeyer A, Griesinger F, Thomas M, 2019. Oncol Res Treat. 2019;42 (suppl. 4)(P413):113 Patients with metastatic non-small cell lung cancer and targetable oncogenic molecular alterations in Germany. Treatment and first outcome data from the prospective German Registry CRISP (AIO-TRK-0315). Griesinger F, Eberhardt WEE, Nusch A, Reiser M, Zahn MO, Marschner N, Jaenicke M, Fleitz A, Spring L, Sahlmann J, Karatas A, Hipper A, Weichert… Weiterlesen Patients with metastatic non-small cell lung cancer without molecular alterations or PD-L1 expression in Germany. Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315). Griesinger F, Eberhardt WEE, Bruch HR, Rauh J, von der Heyde E, Marschner N, Jaenicke M, Fleitz A, Spring L, Sahlmann J, Karatas A, Hipper… Weiterlesen